FDA inspection
IDO PHARM: FDA inspection ending Nov 13, 2025
FDA inspection 1296692 · Official Action Indicated (OAI) · Ansan
Key facts
| Inspection ID | 1296692 |
|---|---|
| Firm | IDO PHARM |
| FEI number | 3017021001 |
| Address | 41 Beonyeongro15beon-Gil, Danwon District |
| City | Ansan |
| Country | Korea (the Republic of) |
| Fiscal year | 2026 |
| Inspection end date | Nov 13, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 723449 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data